122 related articles for article (PubMed ID: 2445238)
1. [Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine and 5-fluorouracil].
Werquin S; Kacet S; Caron J; Lacroix D; Libersa C; Coget JM; Lekieffre J
Ann Cardiol Angeiol (Paris); 1987 Oct; 36(8):409-12. PubMed ID: 2445238
[TBL] [Abstract][Full Text] [Related]
2. [Raynaud's disease after treatment with bleomycin and vinblastine].
Dzieza-Lalowicz I; Mykała-Cieśla J
Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
[No Abstract] [Full Text] [Related]
3. [Raynaud's phenomenon following combined cytostatic treatment of malignant testicular tumours].
Scheulen ME; Schmidt CG
Dtsch Med Wochenschr; 1982 Oct; 107(43):1640-4. PubMed ID: 6183087
[TBL] [Abstract][Full Text] [Related]
4. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
[TBL] [Abstract][Full Text] [Related]
5. Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma.
Reiser M; Bruns C; Hartmann P; Salzberger B; Diehl V; Fätkenheuer G
Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):58-60. PubMed ID: 9512187
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma.
Hladunewich M; Sawka C; Fam A; Franssen E
J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644
[TBL] [Abstract][Full Text] [Related]
7. Cortical blindness and seizures possibly related to cisplatin, vinblastine, and bleomycin treatment of ovarian dysgerminoma.
Young DC; Mitchell A; Kessler J; Christman JE
J Am Osteopath Assoc; 1993 Apr; 93(4):502-4, 507. PubMed ID: 7683015
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
Dunlop PR; Hendy-Ibbs PM
Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
[No Abstract] [Full Text] [Related]
9. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy.
Rothberg H; Varney JK
J Med Soc N J; 1978 Nov; 75(12):845-6. PubMed ID: 81878
[No Abstract] [Full Text] [Related]
10. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
[TBL] [Abstract][Full Text] [Related]
11. Raynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinoma.
Teutsch C; Lipton A; Harvey HA
Cancer Treat Rep; 1977 Aug; 61(5):925-6. PubMed ID: 70274
[No Abstract] [Full Text] [Related]
12. Raynaud's phenomenon following cytotoxic chemotherapy successfully managed by dorsal sympathectomy.
MacLeod PM; Tyrrell CJ; Bliss B
Eur J Surg Oncol; 1989 Feb; 15(1):79-81. PubMed ID: 2465189
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin-induced Raynaud's phenomenon and acral sclerosis.
Snauwaert J; Degreef H
Dermatologica; 1984; 169(4):172-4. PubMed ID: 6209171
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-associated Raynaud's phenomenon in a two-year-old girl.
McGuire WA; Passo MH; Weetman RM
Med Pediatr Oncol; 1985; 13(6):392-4. PubMed ID: 2413340
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin-vinblastine associated Raynaud's phenomenon.
Paty JG; Ruffner BW
J Rheumatol; 1980; 7(6):927-8. PubMed ID: 6162955
[No Abstract] [Full Text] [Related]
16. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy.
Rothberg H
Cancer Treat Rep; 1978 Apr; 62(4):569-70. PubMed ID: 77726
[No Abstract] [Full Text] [Related]
17. Raynaud's phenomenon in a child with medulloblastoma as a late effect of chemotherapy.
Atas E; Korkmazer N; Artik HA; Babacan O; Kesik V
J Cancer Res Ther; 2015; 11(3):666. PubMed ID: 26458705
[TBL] [Abstract][Full Text] [Related]
18. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
Vogelzang NJ; Torkelson JL; Kennedy BJ
Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
[TBL] [Abstract][Full Text] [Related]
19. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of advanced testicular cancer.
Einhorn LH
Prog Clin Biol Res; 1985; 203():411-35. PubMed ID: 2421334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
